{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:30:47Z","timestamp":1793518247400,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["304925"],"award-info":[{"award-number":["304925"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The standard therapy for patients suffering from sensorineural hearing loss is cochlear implantation. The insertion of the electrode array into the cochlea, with potential mechanical trauma and the presence of this foreign body inside the cochlea, may lead to free radical formation and reduced blood perfusion of the cochlea which can result in a loss of residual hearing. Studies have suggested that a particular combination of the antioxidants vitamins A, C and E as well as the vasodilator magnesium (together: ACEMg) may protect the residual hearing.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The potential protective effect of ACEMg on residual hearing preservation in cochlear implant (CI) patients was investigated in a single-centre, randomized, placebo-controlled, double-blind phase II clinical trial. CI candidates with some residual hearing in low frequencies receiving MED-EL implants of different FLEX electrode array lengths were treated with ACEMg tablets or placebo respectively 2\u2009days preoperatively and up to 3\u2009months postoperatively. The study objective was to demonstrate that ACEMg is more efficacious than placebo in preserving residual hearing during cochlear implantation by comparing the hearing loss (change in hearing thresholds at 500\u2009Hz from baseline) 3\u2009months after the first fitting between the two treatment groups and to investigate the treatments\u2019 safety.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Fifty-one patients were included in the study, which had to be terminated before the recruitment goal was reached because of IMP-resupply mismanagement of one partner. In the intention-to-treat population, 25 patients were treated with ACEMg and 24 patients with placebo. The mean hearing loss at 500\u2009Hz was (\u00b1\u200915.84) 30.21\u2009dB (placebo) or (\u00b1\u200917.56) 26.00\u2009dB (ACEMg) 3\u2009months after the initial fitting. Adjusting the postoperative hearing loss for the baseline residual hearing, planned electrode length and surgeon results in 8.01\u2009dB reduced hearing loss in ACEMg-treated patients compared to placebo-treated ones. The safety analysis revealed that ACEMg was generally well-tolerated with adverse event frequencies below the placebo level.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This is the first clinical trial investigating a drug effect on residual hearing in CI patients. These first-in-man data may suggest that a perioperative oral administration of ACEMg is safe and may provide protection of residual hearing in CI patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>EU Clinical Trial Register No. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2012-005002-22\">2012-005002-22<\/jats:ext-link>. Registered on 6 December 2013. Funding: European Commission FP7-HEALTH-2012-INNOVATION-2.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13063-020-04522-9","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T13:29:27Z","timestamp":1594733367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8618-8793","authenticated-orcid":false,"given":"Verena","family":"Scheper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Schmidtheisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4889-0212","authenticated-orcid":false,"given":"Florian","family":"Lasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"von der Leyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Schwieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"B\u00fcchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Lesinski-Schiedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lenarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"4522_CR1","volume-title":"Cochlear implant information sheet","author":"Foundation TE","year":"2019","unstructured":"Foundation TE. Cochlear implant information sheet. 2019; Available from: www.earfoundation.org.uk."},{"key":"4522_CR2","unstructured":"Lenarz T, Scheper V. Preserving Residual Hearing in Cochlear Implant Patients. in \u201cFree Radicals in ENT Pathology\u201d. Eds.: Miller J, LePrell CG, Rybak L. Springer; 2015. ISBN 978-3-319-13473-4."},{"key":"4522_CR3","doi-asserted-by":"publisher","unstructured":"Dhanasingh A, Jolly C. An overview of cochlear implant electrode array designs. Hear Res. 2017;356:93\u2013103. https:\/\/doi.org\/10.1016\/j.heares.2017.10.005.","DOI":"10.1016\/j.heares.2017.10.005"},{"issue":"6","key":"4522_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1749-4486.2008.01822.x","volume":"33","author":"KN Talbot","year":"2008","unstructured":"Talbot KN, Hartley DE. Combined electro-acoustic stimulation: a beneficial union? Clin Otolaryngol. 2008;33(6):536\u201345 Epub 2009\/01\/08.","journal-title":"Clin Otolaryngol"},{"issue":"1","key":"4522_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MAO.0b013e318277a44e","volume":"34","author":"S Helbig","year":"2013","unstructured":"Helbig S, Rajan GP, Stover T, Lockley M, Kuthubutheen J, Green KM. Hearing preservation after cochlear reimplantation. Otol Neurotol. 2013;34(1):61\u20135 Epub 2012\/12\/04.","journal-title":"Otol Neurotol"},{"issue":"5","key":"4522_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000360601","volume":"19","author":"MC Jurawitz","year":"2014","unstructured":"Jurawitz MC, Buchner A, Harpel T, Schussler M, Majdani O, Lesinski-Schiedat A, et al. Hearing preservation outcomes with different cochlear implant electrodes: nucleus(R) hybrid-L24 and nucleus freedom CI422. Audiol Neurootol. 2014;19(5):293\u2013309 Epub 2014\/10\/04.","journal-title":"Audiol Neurootol"},{"issue":"12","key":"4522_CR7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3109\/14992027.2013.802032","volume":"52","author":"T Lenarz","year":"2013","unstructured":"Lenarz T, James C, Cuda D, Fitzgerald O\u2019Connor A, Frachet B, Frijns JH, et al. European multi-centre study of the nucleus hybrid L24 cochlear implant. Int J Audiol. 2013;52(12):838\u201348 Epub 2013\/09\/03.","journal-title":"Int J Audiol"},{"issue":"8","key":"4522_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/MAO.0000000000001110","volume":"37","author":"MC Suhling","year":"2016","unstructured":"Suhling MC, Majdani O, Salcher R, Leifholz M, Buchner A, Lesinski-Schiedat A, et al. The impact of electrode array length on hearing preservation in cochlear implantation. Otol Neurotol. 2016;37(8):1006\u201315 Epub 2016\/06\/17.","journal-title":"Otol Neurotol"},{"issue":"Suppl 1","key":"4522_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/lary.23902","volume":"123","author":"AA Eshraghi","year":"2013","unstructured":"Eshraghi AA, Gupta C, Van De Water TR, Bohorquez JE, Garnham C, Bas E, et al. Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c-Jun-N-terminal kinase signaling. Laryngoscope. 2013;123(Suppl 1):S1\u201314 Epub 2013\/02\/06.","journal-title":"Laryngoscope"},{"issue":"11","key":"4522_CR10","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/ar.22585","volume":"295","author":"E Bas","year":"2012","unstructured":"Bas E, Gupta C, Van De Water TR. A novel organ of corti explant model for the study of cochlear implantation trauma. Anat Rec (Hoboken). 2012;295(11):1944\u201356 Epub 2012\/10\/10.","journal-title":"Anat Rec (Hoboken)"},{"issue":"11","key":"4522_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/ar.22574","volume":"295","author":"E Bas","year":"2012","unstructured":"Bas E, Dinh CT, Garnham C, Polak M, Van de Water TR. Conservation of hearing and protection of hair cells in cochlear implant patients\u2019 with residual hearing. Anat Rec (Hoboken). 2012;295(11):1909\u201327 Epub 2012\/10\/10.","journal-title":"Anat Rec (Hoboken)"},{"key":"4522_CR12","doi-asserted-by":"publisher","unstructured":"Souza MEDCA, Costa KVTD, Vitorino PA, Bueno NB, Menezes PL. Effect of antioxidant supplementation on the auditory threshold in sensorineural hearing loss: a meta-analysis. Braz J Otorhinolaryngol. 2018;84(3):368\u201380. https:\/\/doi.org\/10.1016\/j.bjorl.2017.07.011.","DOI":"10.1016\/j.bjorl.2017.07.011"},{"issue":"9","key":"4522_CR13","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.freeradbiomed.2007.02.008","volume":"42","author":"CG Le Prell","year":"2007","unstructured":"Le Prell CG, Hughes LF, Miller JM. Free radical scavengers vitamins A, C, and E plus magnesium reduce noise trauma. Free Radic Biol Med. 2007;42(9):1454\u201363.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"4522_CR14","first-page":"375","volume":"15","author":"CG Le Prell","year":"2014","unstructured":"Le Prell CG, Ojano-Dirain C, Rudnick EW, Nelson MA, DeRemer SJ, Prieskorn DM, et al. Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity. J Assoc Res Otolaryngol. 2014;15(3):375\u201393 Epub 2014\/03\/05.","journal-title":"J Assoc Res Otolaryngol"},{"key":"4522_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fnagi.2015.00086","volume":"7","author":"JC Alvarado","year":"2015","unstructured":"Alvarado JC, Fuentes-Santamaria V, Melgar-Rojas P, Valero ML, Gabaldon-Ull MC, Miller JM, et al. Synergistic effects of free radical scavengers and cochlear vasodilators: a new otoprotective strategy for age-related hearing loss. Front Aging Neurosci. 2015;7:86.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4522_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.trsl.2011.02.006","volume":"158","author":"CG Le Prell","year":"2011","unstructured":"Le Prell CG, Gagnon PM, Bennett DC, Ohlemiller KK. Nutrient-enhanced diet reduces noise-induced damage to the inner ear and hearing loss. Transl Res. 2011;158(1):38\u201353.","journal-title":"Transl Res"},{"issue":"1\u20132","key":"4522_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.heares.2009.08.010","volume":"259","author":"H Eastwood","year":"2010","unstructured":"Eastwood H, Pinder D, James D, Chang A, Galloway S, Richardson R, et al. Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation. Hear Res. 2010;259(1\u20132):24\u201330 Epub 2009\/09\/08.","journal-title":"Hear Res"},{"key":"4522_CR18","unstructured":"NICE. Cochlear implants for children and adults with severe to profound deafness: technology appraisal guidance - TA1066. National Institute for Health and Clinical Excellence. 2009. [September 2019]; Available from: http:\/\/www.nice.org.uk\/guidance\/ta166."},{"key":"4522_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13063-016-1526-7","volume":"17","author":"V Scheper","year":"2016","unstructured":"Scheper V, Leifholz M, von der Leyen H, Keller M, Denkena U, Koch A, et al. ACEMg-mediated hearing preservation in cochlear implant patients receiving different electrode lengths (PROHEARING): study protocol for a randomized controlled trial. Trials. 2016;17:394 Epub 2016\/08\/10.","journal-title":"Trials"},{"issue":"Suppl 1","key":"4522_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000206492","volume":"14","author":"T Lenarz","year":"2009","unstructured":"Lenarz T, Stover T, Buechner A, Lesinski-Schiedat A, Patrick J, Pesch J. Hearing conservation surgery using the hybrid-L electrode. Results from the first clinical trial at the Medical University of Hannover. Audiol Neurootol. 2009;14(Suppl 1):22\u201331 Epub 2009\/04\/29.","journal-title":"Audiol Neurootol"},{"issue":"2","key":"4522_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/gg.2017.0006","volume":"1","author":"TL Cornelison","year":"2017","unstructured":"Cornelison TL, Clayton JA. Considering sex as a biological variable in biomedical research. Gender Genome. 2017;1(2):89\u201393.","journal-title":"Gender Genome"},{"issue":"2","key":"4522_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/lary.26714","volume":"128","author":"GB Wanna","year":"2018","unstructured":"Wanna GB, O\u2019Connell BP, Francis DO, Gifford RH, Hunter JB, Holder JT, et al. Predictive factors for short- and long-term hearing preservation in cochlear implantation with conventional-length electrodes. Laryngoscope. 2018;128(2):482\u20139.","journal-title":"Laryngoscope"},{"issue":"6","key":"4522_CR23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.14639\/0392-100X-619","volume":"35","author":"D Zanetti","year":"2015","unstructured":"Zanetti D, Nassif N, Redaelli de Zinis LO. Factors affecting residual hearing preservation in cochlear implantation. Acta Otorhinolaryngol Ital. 2015;35(6):433\u201341.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"3","key":"4522_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/MAO.0b013e318281e0c9","volume":"34","author":"PL Santa Maria","year":"2013","unstructured":"Santa Maria PL, Domville-Lewis C, Sucher CM, Chester-Browne R, Atlas MD. Hearing preservation surgery for cochlear implantation--hearing and quality of life after 2 years. Otol Neurotol. 2013;34(3):526\u201331.","journal-title":"Otol Neurotol"},{"issue":"Suppl 1","key":"4522_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000095614","volume":"11","author":"WK Gstoettner","year":"2006","unstructured":"Gstoettner WK, Helbig S, Maier N, Kiefer J, Radeloff A, Adunka OF. Ipsilateral electric acoustic stimulation of the auditory system: results of long-term hearing preservation. Audiol Neurootol. 2006;11(Suppl 1):49\u201356 Epub 2006\/10\/26.","journal-title":"Audiol Neurootol"},{"issue":"5","key":"4522_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1044\/1092-4388(2006\/077)","volume":"49","author":"WN Yao","year":"2006","unstructured":"Yao WN, Turner CW, Gantz BJ. Stability of low-frequency residual hearing in patients who are candidates for combined acoustic plus electric hearing. J Speech Lang Hear Res. 2006;49(5):1085\u201390.","journal-title":"J Speech Lang Hear Res"},{"key":"4522_CR27","unstructured":"Belenguer-Varea A, Tarazona-Santabalbina FJ, Avellana-Zaragoza JA, Ingles M, Mas-Bargues C, Martinez-Reig M. Oxidative stress and exceptional human longevity: systematic review. Free Radic Biol Med. 2019; Epub 2019\/09\/25."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04522-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-04522-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04522-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:09:17Z","timestamp":1626221357000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04522-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4522"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04522-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed by The German Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM), application number 4039192, and registered on December 6, 2013, with protocol amendment version 3.0 from August 19, 2014. EudraCT number: 2012-005002-22 (). All patients gave written consent to participate in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"643"}}